A series of 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-based photosensitizers (AmBXI, X = H, M, Br) featuring a cationic mitochondrion-targeting group and near-infrared (NIR) absorption was synthesized. After extending the photosensitizers’ π conjugation via Knoevenagel reaction, both the absorbance and emission maxima of AmBXI shifted to the phototherapeutic wavelength range (650–900 nm). Theoretical computations indicate that the introduction of bromine atoms promotes spin–orbit coupling, so that for each additional bromine atom in AmBXI an increase in singlet oxygen quantum yield would be expected (0.3%, 2.2%, and 4.1%, for AmBHI, AmBMI, and AmBBrI, respectively). Moreover, AmBXI photosensitizers exhibited low cytotoxicity in the dark and high phototoxicity, with the half maximal inhibitory concentrations of AmBBrI found to be 46.93 nM and 22.84 nM, while those of AmBMI were 129.7 nM and 58.34 nM in HeLa and MCF-7 cancer cells, respectively. Notably, introduction of a single bromine atom was enough to produce a cytotoxic effect. Furthermore, the presence of a quaternary ammonium group in AmBXI enabled the dyes to localize and stain the negatively charged mitochondria. The results presented herein indicate the straightforward and facile synthesis of NIR-light triggered mitochondrion-targeting photosensitizers.

The straightforward synthesis of three cationic boron-dipyrromethene (BODIPY) derivatives and their mitochondria-targeting and photodynamic therapeutic (PDT) capabilities are reported. Two cancer cell lines (HeLa and MCF-7) were used to investigate the PDT activity of the dyes. Compared to their non-halogenated counterparts, halogenated BODIPY dyes exhibit lower fluorescence quantum yields and enable the efficient production of singlet oxygen species. Following LED light irradiation at 520 nm, the synthesized dyes displayed good PDT capabilities against the treated cancer cell lines, with low cytotoxicity in the dark. In addition, functionalization of the BODIPY backbone with a cationic ammonium moiety enhanced the hydrophilicity of the synthesized dyes and, consequently, their uptake by the cells. The results presented here collectively demonstrate the potential of cationic BODIPY-based dyes as therapeutic drugs for anticancer photodynamic therapy.

A series of 1-methylpyridinium-substituted brominated distyryl-BODIPY dyes, PyB X I ( X = H, M, or Br), was synthesized to achieve cooperative singlet oxygen ( ¹ O ₂ ) production through qualitatively different dual intersystem crossing (ISC) pathways: spin–orbit charge-transfer ISC (SOCT-ISC) and heavy-atom-induced ISC. Upon photoexcitation of the PyB X I dyes, charge-transfer states were preferentially formed through photoinduced electron transfer from the distyryl-BODIPY core to the 1-methylpyridinium moiety, however, followed by nonradiative charge recombination rather than the desired SOCT-ISC. This resulted in negligible fluorescence and ¹ O ₂ quantum yields in the non-brominated dye PyBHI. The introduction of bromine atoms improved ¹ O ₂ quantum yield from 0.0034 for the mono-brominated dye PyBMI to 0.0061 for the di-brominated dye PyBBrI, attributable to the heavy atom effect. Nonetheless, the ¹ O ₂ production efficiency of these dyes remained limited, as photoinduced electron transfer was considered to occur nearly two orders of magnitude faster than singlet-to-triplet ISC. In vitro assays using MCF-7 and HeLa cells demonstrated that PyBBrI induced significant cell death, with IC ₅₀ values of ca. 95 and 220 nM, respectively, confirming its potential for use in cancer therapy.